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SUMMARY: Hyperglycaemia is one of the main causes for the endothelial cell (EC) damage in diabetic patients. Even though
circulating endothelial progenitor cells (CEPC) could be used as a prognosis for microvascular complications, there is very little information
on the islet microvasculature. We analysed by immunohistochemistry and by flow cytometric immunophenotyping, the expression of
CD34 on EC and the expressions of CD31, CD34, CD45 and CD133 on CEPC in Streptozotocin (STZ)-induced diabetic rats. Peripheral
blood and tissue specimens were obtained from rats of different treatment regimens: STZ treatment, control saline (NS) and sodium
citrate (CB) treatments. Blood cells were exposed to flow cytometric immunophenotyping for CD133, CD31, CD34, CD45 and CD133.
While tissues from the pancreas, liver and kidney were routinely processed and stained immunohistochemically for CD34. There was a
tendency of an increased in CD45-/CD133+/CD31+/CD34+ cells (0.04 ± 0.11 %) in diabetic rats compared to the controls (CB: 0.03 ±
0.04 %; Saline: 0.01 ± 0.03 %). But there was no significant statistical difference between them. The expression pattern of CD34 on the
EC in the organs’ vascular beds including arterioles, venules, capillaries and sinusoids was extremely heterogeneous across and within
treatment regimens. The ECs in the sinusoids of the liver presented similar CD34 expression patterns across different treatment regimens,
while the expression of CD34 on the ECs of sinusoidal capillaries in the pancreas vary with the treatment regimen. We conclude that the
degree of endothelial cell damage is not uniform across organs’ vascular beds in the rat, contrary to mice and humans. Furthermore, the
sinusoids in the pancreas and the kidney may have the same degree of endothelial damage when exposed to the same deleterious causes.
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INTRODUCTION
Circulating endothelial progenitor cells (CEPCs) are
hematopoietic cells released by the bone marrow into the
blood in response to vascular damage (Asahara et al., 1997).
Circulating endothelial progenitor cells mobilise to the sites
of damaged tissue to induce vascular repair, but their
recruitments are impaired by hyperglycaemia (Thangarajah
et al., 2010). Chronic hyperglycaemia, as a result of Diabe-
tes mellitus (DM), increases reactive oxygen species (ROS)
levels leading to oxidative stress (King & Loeken, 2004),
which in turn causes endothelial cell (EC) activation. This
inflammatory and immunological response (Hunt & Jurd,
1998) is characterised by vascular endothelial hypertrophy
and thickening, leading to permanent EC damage (Zhang
et al., 2010). A number of studies (Liao et al., 2010; Chen
et al., 2013; Liu et al., 2013; Rigato et al., 2015) have been
published with the intention to use the levels of CEPCs as
a prognosis for chronic kidney disease, cardiovascular
disease, liver disease, retinopathy and vascular endothelial
function. Hence, scarce data are available on the
immunohistomorphology of microvascular ECs for CD34
and the expression of CEPCs for commonly used EC
markers like CD31, CD34, CD45 and CD133 in the
pancreas tissue in a diabetic rat, in comparison with that of
the kidneys and liver.
CD31, a member of the immunoglobulin superfamily,
functions during inflammation and angiogenesis in
facilitating the migration of leucocyte between ECs,
respectively (Feng et al., 2004). It stains plasma cells,
monocytes, and megakaryocytes. CD34 plays a role in
hematopoietic stem cell and leukocyte recruitment by acting
as a regulating blocker of cell adhesion and migration
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enhancer (Nielsen & McNagny, 2009). It is commonly used
as a marker for vascular ECs and for hematopoietic stem
cell purification (Nielsen & McNagny). CD45 is a receptor-
linked protein tyrosine phosphatase expressed on all
leucocytes. The antigen, which is also expressed on all
nucleated hematopoietic cells, is important for the function
and activation of leucocytes (Hermiston et al., 2003). CD133
however, is a member of the prominin family of pantaspan
membrane proteins and is responsible for maintaining proper
lipid composition within the plasma membrane (Mizrak et
al., 2008). It is commonly used as a marker for primitive
haematopoietic and neural stem cells (Mizrak et al.).
The present study was undertaken to analyse
immunohistochemically, and by flow cytometric
immunophenotyping the expression of microvascular
endothelium for CD34 and the expression of CEPCs for
CD31, CD34, CD45 and CD133 in Streptozotocin (STZ)-
induced diabetes rat tissue, respectively. For a comprehensive
analysis, we studied two organs in comparison with the
pancreas but focused mainly on the endothelial damage in
microvasculature of the (pancreatic islet of Langerhans),
(glomerular capsule Bowman’s capsule) and the liver acinus,
using the expression of CD34.  We also used monoclonal
CD31, CD34, CD45 and polyclonal CD133 antibodies that
have been recognized as a common combination of anti-
bodies in the identification of CEPCs (Hirschi et al., 2008).
MATERIAL AND METHOD
Animal. Adult male Wistar rats (225-245 g) were obtained
and housed in a temperature-controlled room, with free
access to water and food. The use of animals for this study
was approved by the Stellenbosch University Animal ethics
committee, in accordance with the South African National
Standard (SANS 10386:2008). The rats were grouped into
treatment regimens of five animals each: the saline (NS)
control group, the sodium citrate buffer (CB) control group
and the Streptozotocin (STZ) diabetes group.
Treatment regimens. Under light anaesthesia, rats
received an IP injection of STZ (50 mg/kg; dissolved in 1
ml CB; experimental rats). Rats were monitored for ten
consecutive days, the body weight (BW) was measured every
two days. Only rats with blood glucose levels (BGL) ≥ 15
Mmol/mL for three consecutive days were considered
diabetic.  For the control groups, rats received an IP injection
of saline solution (NS; 1 ml; NS control rats) or sodium
citrate buffer (CB; 1 ml; CB control rats). Rats in all groups
were kept for 40 days and the bodyweight and blood glucose
levels (BGL) were monitored every two days.
Blood sample and tissue collection and processing. A
day prior to tissue collection, blood samples were obtained
and analysed for CEPC expression using flow cytometry.
The anti-bodies used in this study are listed in Table I. The
flow cytometer was set to acquire a maximum of 1 000
000 events during a 10 minute period. The gating strategy
used in flow cytometry analysis to detect different subsets
of circulating hematopoietic cells is shown in Figure 1.
Viable cells which include all single and living cells were
first gated from the total events and were expressed as
percentage of the mean. The expression of CD45 was used
to gate lymphocytes and granulocytes from viable cells.
However, the expression of CD133 was gated from the
resulted CD45+/- cells and grouped into CD45-/CD133+
and CD45+/CD133+ cells. Furthermore, the expression
of CD31 vs. CD34 was then gated from CD45+/CD133+
and CD45-/CD133+ cells and expressed as CD45+/
CD133+/CD31+/CD34+ and CD45-/CD133+/CD31+/
CD34+ cells. CD45-/CD133+/CD31+/CD34+ cells were
characterised as CEPCs.
Tissue sections at 3 µm each were cut from each
tissue block representing each organ in the corresponding
treatment groups, and were mounted on positively charged
microscope slides. A BondMax™ immunoautostainer was
used to stain slides using a modified F protocol for a Bond
Polymer Refine detection kit (Code: DS9800) (Leica
Biosystems, Wetzlar, Germany). Human tonsil was used
as a positive and negative control. A Zeiss Axioskop
microscope (Carl Zeiss, Oberkochen, Germany) was used
to visualise and capture the stained tissue images.
Drugs. The following drugs and reagents were used in
this study: Streptozotocin (Sigma-Aldrich, Missouri USA),
Sodium citrate buffer (Kimix Chemicals S.A., Cape Town,
RSA).
Antibody Dilution Source Clone Incubation
Monoclonal CD34 1/100000 Abcam, Cambridge, UK EP373Y 60 min
Monoclonal CD31 0.5/100000 Abcam, Cambridge, UK TLD-3A12 60 min
Polyclonal CD133 2/100000 Abnova, Taipei city, TW 8842 60 min
Monoclonal CD45 2/100000 Biolegend, California, USA OX-1 60 min
Monoclonal CD34* 1/500 Abcam, Cambridge, UK ICO-115 30 min
* Antibody used for immunohistochemistry.
Table I. Antibodies used in the study.
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Statistical analysis. The flow cytometry data was analysed
using GraphPad Prism 5 software (GraphPad software Inc.).
One way Kruskal-Wallis test was performed for comparison
between groups followed by a Dunn’s post-test. The results
are presented as mean ± standard error of the mean (SEM)
percentage. The significance level was set at p < 0.05.
Fig. 1. (A) A gate was drawn around single cells in a FS
peak vs. FS interval dotplot. (B) Single cells were gated
for viable (living) cells in a FS interval vs. Zombie
VioletTM dotplot.  (C) Lymphocytes and granulocytes were
gated out from single viable cells using a FS interval vs.
CD45-AF700 dotplot. (D) The cells were further gated for
CD45+/CD133+ and CD45-/CD133+ cells using a CD133-
APC vs. CD45-AF700 dotplot. (E) CD31-FITC vs. CD34-
PE dotplot was then drawn to gate CD45-/CD133+/CD31+/
CD34+ cells (CEPCs).
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RESULTS
Body weight and blood glucose levels. The mean BW and
BGL in all the groups are shown in Figure 2. The BW in the
CB control group had a sharp increase above the mean value
reaching 329.0 g on day 40 of the experiment, while the
BGL in this group was steady and similar (5.68 mmol/L)
with the NS control group. However, the mean BW in the
diabetes rats dropped on day 5 post-STZ treatment (207.00
g) and rose steadily throughout the experimental period
toward the NS control level (219.00 g); in the same time,
the mean BGL had a sharp increase (28.4 mmol/L) following
STZ injection and dropped (23.16 mmol/L) on day 5 post-
STZ treatment. Thereafter, there was a fluctuation of the
mean BGL levels from day 7 (24.78 mmol/L) until day 40
(23.84 mmol/L), during which a peak level of mean BGL
(28.60 mmol/L) was reached on day 11 and its nadir (19.46
mmol/L) on day 15.
Immunophenotypic analysis. The percentage of CEPC
populations and viable cells in rats of different treatment
regimens is shown in Table II. These results suggest that an
increase in CEPCs levels may not be associated with the
number of viable cells, but with the treatment regimen used.
Immunohistomorphological study. The expression pattern
for CD34 in the ECs of the vascular beds including arterioles,
venules, capillaries and sinusoids of different organs in this
study was extremely heterogeneous across treatment
regimens, and slightly within groups; and are summarized
in Table III. The immunohistomorphology of the organs
represented in Figures 4, 5 and 6 presented some
characteristic features specific to the treatment regimens.
Pancreatic islet : The diabetic rat pancreas had dilated acinar
cells with decreased cell density in the islet, while there were
some fibrotic areas indicative of beta-cell loss. The sinusoidal
capillaries had a strong positivity for CD34 in the diabetic
rats, but weak positivity in the interlobular capillaries (Fig.
Variable Diabetic
STZ treatment
Control
CB treatment
Control
NS treatment
Total events n = 507414 n = 635529 n = 482363
Viable cells 68.80 % 76.73 % 78.85 %
CD45+ and CD45- 15.33 – 3.87 % 12.76 – 2.71 % 15.39 – 1.79 %
CD45-/CD133+ 4.50 – 1.17 % 4.37 – 1.49 % 6.03 – 0.64 %
CD45+/CD133+ 8.09 – 3.42 % 4.02 – 1.39 % 5.72 – 1.60 %
CD45+/CD133+/CD31+/CD34+ 0.09 – 0.03 % 0.21 – 0.25 % 0.05 – 0.13 %
CD45-/CD133+/CD31+/CD34+* 0.11 – 0.04 % 0.04 – 0.03 % 0.03 – 0.01 %
3A). The pancreas of the CB control rats had relatively nor-
mal acini; however, the islets displayed oedema and numerous
lymphocytic infiltrations. The interlobular capillaries strongly
expressed CD34 in the CB control rats while the sinusoidal
capillaries had low to absent positive expressions for CD34
(Fig. 3B). Conversely, the pancreas in the NS control rats had
normal morphology, with healthy islets. The interlobular
capillaries were strongly positive for CD34 in the NS control
rats, while the sinusoidal capillaries had low positive
expression (Fig. 3C).
The liver acinus: The liver in diabetic rats had more
extensive hypertrophy hepatocytes in the periportal region.
The portal vein was completely detached from the
Fig. 2. Graphs (A) showing BGL in the rats of different treatment
regimens and (B) their BW throughout the experimental period.
Table II. Percentage of CEPC populations and viable cells in rats with different regimens.
* CD45-/CD133+/CD31+/CD34+ cells are CEPCs.
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underlining connective tissues. Weak positivity for CD34
was observed in the ECs of the portal vein and hepatic artery
in this group (Fig. 4A), while moderate positivity for CD34
was expressed in the CB control rats. However, the swelling
of periportal hepatocyte was observed, having numerous
lymphocytic infiltrations (Fig. 4B). The ECs in the portal
vein and hepatic artery were highly positive for CD34 in
NS control rats; the morphology of the periportal hepatocytes
and that of the portal triad was normal (Fig. 4C). The
sinusoids in all the groups were negative for CD34.
Fig. 3. (A) CD34 expression in the STZ treated group
showing the islet sinusoidal capillaries with moderate
positivity for CD34, and interlobular capillaries weak
positive expression. (B)  Similar moderate positivity for
CD34 is showing in the islet sinusoidal capillaries in the
CB treated group, with interlobular capillaries showing
absent to very weak positive expression for CD34. (C)
However the interlobular capillaries showing very strong
positivity for CD34 in the NS treated group.
Table III. Staining of ECs for CD34 in various rats with different treatment regimens.
Intensity of immunohistochemical staining: 0, absent; +, low; ++, medium; +++, high.
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Tissue Diabetic
STZ treatment
Control
CB treatment
Control
NS treatmentPancreas
Sinusoidal capillaries +++ ++ +
Interlobular capillaries + 0/+ +++
Liver
Hepatic arteries ++ ++ +++
Portal veins ++ ++ +++
Sinusoids 0 0 0
Kidney
Glomeruli +++ ++ +
Capillaries +++ ++ 0/+
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Fig. 4. (A) The sinusoids are negative for CD34
in the STZ treated group, but the hepatic arteries
and portal veins are positively moderately stained.
(B) Similarly in the CB treated group, the
sinusoids were negative for CD34, while the
hepatic artery and portal vein are positively
moderately stained. (C) CD34 expression
showing strong positivity in hepatic arteries and
portal veins in the NS treated group; while the
sinusoids are negative for CD34.
Fig. 5. (A) The glomeruli and the capillaries
showing strong positivity for CD34 in the STZ
treated group. (B) The glomeruli and the
capillaries are moderately positive for CD34 in
the CB treated group. (C) While in the NS treated
group the glomeruli have low positivity for CD34,
with poorly stained capillaries.
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The glomerular capsule of the kidney: The kidney tissue
section in the diabetic rats had an atrophy of the glomerular
capsule characterised by a decreased glomerular vessel
density. The ECs of the glomeruli and the capillaries had a
strong positive expression for CD34 (Fig. 5A). In the CB
control rats, the urinary space and the mesangial cells within
the glomerulus was swollen due to oedema; while enlarged
proximal convoluted tubule and distal convoluted tubules
was observed. The glomeruli and the capillaries were weakly
or moderately positive for CD34 (Fig. 5B). However, the
NS control rats presented with diffuse positivity for CD34,
having a normal kidney morphology and healthy renal
corpuscles and tubules (Fig. 5C).
The irrational intensity of the immunohistochemical
staining observed between various vascular beds of
different organs within individual groups of treatment
regimen strongly advocate that, the endothelial cell damage
in vascular beds is limited in its distribution across organs.
Interestingly, there were similarities in the staining intensity
between the sinusoidal capillaries in the pancreas and in
the glomeruli of the kidney under the same treatment
regimen. This is an indication that sinusoids in the pancreas
and the kidney may have the same degree of endothelial
damage when exposed to the same deleterious causes.
DISCUSSION
In this study, we analysed the expression of
microvascular endothelium for CD34 and the expression
of CEPCs for CD31, CD34, CD45 and CD133 in the
pancreas in comparison with the liver and the kidney in
the diabetic rat. Our study confirms that the EC vascular
damage is restricted in its distribution in Wistar rats (Testa
et al., 2009). This was elucidated by the staining intensity
of ECs for CD34 that was not identical in various vascular
beds under the same treatment regimen (Table III). There
were remarkable similarities in the staining intensity
between the sinusoidal capillaries in the pancreas and the
glomeruli of the kidney under the same treatment regimen.
Moreover, the analysis of the BW and the BGL in
this study showed a considerable weight gain in the CB
control group, while the BGL in the control groups were
similar. These findings confirm the oedematous effect of
CB alone (Cunha et al., 2009) in the rats, and may suggest
that the CB used as a solute to dissolve STZ drug does not
have any remarkable impact on the histomorphology of
STZ treated organs. The severity of STZ-induced diabetes
and its effects were apparent on the morphology of the
pancreas (Fig. 3A), the liver (Fig. 4 A) and the kidney
(Fig. 5A). Additionally, the BGL in the diabetic rats
remained high in the study and there was a tendency of
increased CEPCs in the diabetic rat compared to the
controls. These findings suggest that CEPC recruitments
to the sites of damaged tissue are not impaired by
hyperglycaemia, contradicting a previous observation
(Thangarajah et al.). Consequently, the mobilization of
CEPCs could be due to the deleterious effects of the
treatment regimen and that hyperglycemia participates very
little in its recruitments.
Previous studies (Jin et al., 2010; Ling et al., 2012;
Zhang & Yan, 2013) have shown that there is a significant
reduction in CEPC levels in STZ-induced diabetic rats.
The discrepancies between our findings and these reports
in the literature can be partly explained by the selection of
the STZ dosage (55 mg/kg; 30 mg/kg; 50 mg/kg), the
timing of its application (not indicated) and other unknown
environmental factors. Furthermore, a relation between
severity of diabetic peripheral arterial disease and reduced
CEPC levels was reported (Fadini et al., 2006), while
suggesting CEPCs as a novel biomarker for peripheral
atherosclerosis in DM. In fact, the latter postulate was from
a study using human participants; it would be difficult to
compare such results with studies done on rats, while
mimicking diabetes using STZ does not represent all the
physiological conditions present in a human.
CONCLUSION
This study confirms that the degree of endothelial
cell damage is not uniform across organs’ vascular beds in
the rat, contrary to mice and humans. However, sinusoids
in the pancreas and the kidney may have the same degree
of endothelial damage when exposed to the same
deleterious causes. We therefore, recommend that a choice
of animal, dosage and timing of the administration of the
drug become a necessary pillar in any study on circulating
endothelial progenitor cells when used as a novel biomarker
for peripheral atherosclerosis using animal model.
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RESUMEN: La hiperglucemia es una de las principales cau-
sas del daño de las células endoteliales (EC) en pacientes diabéticos.
A pesar de que las células progenitoras endoteliales circulantes
(CEPC) podrían utilizarse como pronóstico de las complicaciones
microvasculares, hay muy poca información sobre la microvasculatura
de los islotes. Se analizaron por inmunohistoquímica y por
inmunofenotipificación citométrica de flujo, la expresión de CD34
en EC y las expresiones de CD31, CD34, CD45 y CD133 en CEPC
en ratas diabéticas inducidas por estreptozotocina (STZ). Se obtu-
vieron muestras de sangre y tejidos periféricos a partir de ratas de
diferentes regímenes de tratamiento: tratamiento con STZ, solución
salina control (NS) y citrato de sodio (CB). Las células sanguíneas
fueron expuestas a inmunofenotipado por citometría de flujo para
CD133, CD31, CD34, CD45 y CD133. Mientras que los tejidos del
páncreas, el hígado y el riñón fueron rutinariamente procesados y
teñidos inmunohistoquímicamente para CD34. Se observó una ten-
dencia a un aumento en las células CD45- / CD133 + / CD31 + /
CD34 + (0,04 ± 0,11 %) en ratas diabéticas en comparación con los
controles (CB: 0,03 ± 0,04 %; Salino: 0,01 ± 0,03 %). Pero no hubo
diferencias estadísticamente significativas entre ellos. El patrón de
expresión de CD34 en la EC en los lechos vasculares de los órganos
incluyendo arteriolas, vénulas, capilares y sinusoides fue extremada-
mente heterogéneo a través de y dentro de los regímenes de trata-
miento. Las EC en los sinusoides del hígado presentaron patrones de
expresión de CD34 similares a través de diferentes regímenes de tra-
tamiento, mientras que la expresión de CD34 en las CE de capilares
sinusoidales en el páncreas varía con el régimen de tratamiento. Con-
cluimos que el grado de daño de las células endoteliales no es unifor-
me en los lechos vasculares de los órganos en la rata, en compara-
ción de los ratones y los seres humanos. Además, los sinusoides en el
páncreas y el riñón pueden tener el mismo grado de daño endotelial
cuando se exponen a las mismas causas deletéreas.
PALABRAS CLAVE: CEPC; CE; Páncreas; Hígado; Riñón.
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